AIM - AIM Notice - 17/06/2026
RNS Number : 5381IAIM17 June 2026NOTICE
17/06/2026 - 08:00
The London Stock Exchange admits the following securities to trading on AIM:
ANGLESEY MINING PLC
772,500
ORDINARY SHARES OF 1P EACH, FULLY PAID
(BVMZHW0)(GB00BVMZHW05)
Faron Pharmaceuticals Oy
21,469,427
ORDINARY SHARE OF NO PAR VALUE; FULLY PAID (DI)
(BYMKYR0)(FI4000153309)
GCM Resources Plc
6,783,575
ORDINARY SHARES OF 1P EACH, FULLY PAID
(B00KV28)(GB00B00KV284)
IQE plc
5,864,624
ORDINARY SHARES OF 1P EACH, FULLY PAID
(0961992)(GB0009619924)
Premier African Minerals Limited
4,000,000,000
ORDINARY SHARES OF NIL PAR VALUE FULLY PAID (DI)
(BNVY1J7)(VGG7223M1187)
If you have any queries or require further information, please contact Market Operations on 020 7797 4310.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDAMOBXGDLXXBDGLL
Recent news on Faron Pharmaceuticals Oy
See all newsFaron Pharmaceuticals: Faron to Report Final Melanoma Survival Data from the MATINS Study at ESMO 2026
Faron Pharmaceuticals: Composition of Faron Pharmaceutical’s Shareholders’ Nomination Board
Convertible bond amortization payment deferred by mutual agreement with HCM
Issuance of warrants
HOLDING(S) IN COMPANY